Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 8/20 | 0.74 |
| ▸ | DHODH | Q02127 | 1/20 | 0.65 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | HTR2B | P41595 | 2/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenoxazine SCHEMBL28350911 | 0.91 | ALOX5 (0.61) | ALOX5DHODHNOX1MAPTGAA | |
| Phenoxazine SCHEMBL27458642 | 0.88 | ALOX5 (0.63) | ALOX5DHODHNOX1MAPTGAA | |
| Phenoxazine SCHEMBL28263385 | 0.88 | ALOX5 (0.57) | ALOX5DHODHNOX1MAPTMEN1 | |
| Phenoxazine SCHEMBL7862 | 0.86 | ALOX5 (1.00) | ALOX5DHODHMAPTGAANPSR1 | |
| Phenoxazine SCHEMBL28844098 | 0.86 | ALOX5 (1.00) | ALOX5DHODHMAPTGAANPSR1 | |
| Phenoxazine SCHEMBL29355714 | 0.86 | ALOX5 (1.00) | ALOX5DHODHMAPTGAANPSR1 | |
| Phenoxazine SCHEMBL6310178 | 0.86 | ALOX5 (1.00) | ALOX5DHODHMAPTGAANPSR1 | |
| Phenoxazine SCHEMBL18770789 | 0.84 | ALOX5 (0.85) | ALOX5DHODHMAPTGAANPSR1 | |
| Phenoxazine SCHEMBL25275195 | 0.84 | ALOX5 (0.94) | ALOX5DHODHMAPTGAANPSR1 | |
| Phenoxazine SCHEMBL5808288 | 0.84 | ALOX5 (0.94) | ALOX5DHODHMAPTGAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113801102-A | Phenazinyl-based compound and preparation method and application thereof | 上海交通大学 | 2021-12-17 | — | — | CN | disclosed |
| CN-107428709-B | Cationic direct dyes | 巴斯夫欧洲公司 | 2021-10-08 | — | — | CN | disclosed |
| CN-103204996-A | Organic electroluminescent device | MERCK PATENT GMBH | 2013-07-17 | — | — | CN | disclosed |
| CN-101171320-B | Organic electroluminescent device | MERCK PATENT GMBH | 2013-04-10 | — | — | CN | disclosed |
| US-8323804-B2 | Partially conjugated polymers, their representation and their use | MERCK PATENT GMBH (DE) | 2012-12-04 | — | — | US | disclosed |
| CN-101155896-B | Organic electroluminescent device | MERCK PATENT GMBH | 2012-08-29 | — | — | CN | disclosed |
| CN-101142294-B | Novel materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2011-12-07 | — | — | CN | disclosed |
| CN-101600777-A | The type material that is used for organic electroluminescence device | MERCK PATENT GMBH (DE) | 2009-12-09 | — | — | CN | disclosed |
| US-20090226759-A1 | Partially Conjugated Polymers, Their Representation and Their Use | MERCK PATENT GMBH (DE) | 2009-09-10 | — | — | US | disclosed |
| EP-2079313-A2 | ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND METHODS FOR THEIR USE | Oligos Etc. Inc. (US) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008133704-A2 | ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND METHODS FOR THEIR USE | OLIGOS ETC., INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| CN-101171320-A | Organic electroluminescent device | MERCK PATENT GMBH (DE) | 2008-04-30 | — | — | CN | disclosed |
| CN-101155896-A | Organic electroluminescent device | MERCK PATENT GMBH (DE) | 2008-04-02 | — | — | CN | disclosed |
| CN-101142294-A | Novel materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2008-03-12 | — | — | CN | disclosed |
| EP-1667947-A1 | METHODS OF 11C -RADIOLABELLING PHENOTHIAZINE AND PHENO THIAZINE-LIKE COMPOUNDS | The University Court of the University of Aberdeen (GB) | 2006-06-14 | — | — | EP | disclosed |
| WO-2005030676-A1 | METHODS OF [11C]-RADIOLABELLING PHENOTHIAZINE AND PHENOTHIAZINE-LIKE COMPOUNDS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2005-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090226759-A1 | Partially Conjugated Polymers, Their Representation and Their Use | MAP1LC3B, PARG, MAP1LC3C | ALOX5 2100/4885DHODH 1565/4885NOX1 1160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.